Position Paper

On Monday, 11 May, Sigma-Aldrich launched the first step in a new initiative called the Science Next Collaborative (SNC).  As an industry first, Sigma Aldrich brought together an elite congress of Australia’s top senior scientists, creating the SNC Think Tank, to discuss how industry and academia can join forces to empower and support early- and mid-career researchers (EMCRs) in translating their research through to commercialisation.

The SNC Think Tank has created a position paper which captures the current situation and key challenges facing EMCRs in Australia. Most importantly, it also offers recommendations to better bridge the gap between industry and academia.

Educational Resources

Commercialisation

Moving into industry

Innovation and Technology

1.
Tips on Commercialisation Professor Peter Karuso Macquarie University
2.
Approaching Industry or Commercialising Research: Some tips from a Science Entrepreneur
3.
Addressing EMCR Commercialisation Challenges: Some tips
4.
Choosing a Patent Attorney
5.
Case Studies on Patenting
6.
The Patent Process
7.
Introduction to Patenting

Moving into industry

Innovation and Technology

1.
Medical Scientific Liaison: An option for EMCRs?
2.
Transitioning into Pharma: Some tips for EMCRS

Commercialisation

Innovation and Technology

1.
Video: Targeted Genome Editing using Sigma CRISPR to identify protein interactions implicated in iron metabolism
2.
The use of Duolink® technology to identify protein interactions implicated in iron metabolism
3.
Polymer Micelles for Drug Delivery
4.
Video: Targeted Genome Editing in Zebrafish using CompoZr® ZFNs
5.
Drug Screening with LOPAC®1280 Delivery

Commercialisation

Moving into industry

Webinars

Watch the Sydney Forum 2015 highlights

Watch the Melbourne Forum 2015 highlights

Watch the Brisbane Forum 2015 highlights

  • 2:00pm
    Welcome and Introduction
    Reich Webber-Montenegro, Director – Marketing, Inside Sales, and Shared Services, Sigma-Aldrich Oceania
  • 2:15pm
    EMCR barriers to commercialisation
    Dr Darren Saunders, Head of Ubiquitin Signalling, Kinghorn Cancer Centre, Garvan Institute
  • 2:25pm
    Tips to successful commercialisation, an Industry perspective
    Ben Perrin, General Manager, SAFC, Sigma-Aldrich Asia Pacific
  • 2:55pm
    Key learnings, an Academic perspective
    Professor Mark Baker, President of HUPO, and Professor of Proteomics & Biochemistry, Macquarie University
  • 3:05pm
    Welcome to Pharma – The life and role of the Medical Science Liaison
    Dr Martijn Bijker, Founder of “from SCIENCE to PHARMA”
  • 3:35pm
    Key learnings, an Academic perspective
    John Carver, Director of the Research School of Chemistry, Australian National University
  • 3:45pm
    The Role of intellectual property in commercialising scientific research
    Karen Sinclair and Dr Grant Jacobsen, Watermark Intellectual Asset Management
  • 4:15pm
    Open Forum (Q&A) – panel discussion
  • 4:45pm
    Networking & Close

Watch the Melbourne Forum 2015 highlights

Watch the Brisbane Forum 2015 highlights

  • 2:00pm
    Welcome and Introduction
    Reich Webber-Montenegro, Director – Marketing, Inside Sales, and Shared Services, Sigma-Aldrich Oceania
  • 2:15pm
    EMCR barriers to commercialisation
    Dr Marguerite Evans-Galea, EMCR, Murdoch Children’s Research Institute
  • 2:25pm
    Tips to successful commercialisation, an Industry perspective
    Ben Perrin, General Manager, SAFC, Sigma-Aldrich Asia Pacific
  • 2:55pm
    Key learnings, an Academic perspective
    Professor Peter Currie (Deputy Director, Australian Regenerative Medicine Institute, Monash University)
  • 3:05pm
    A career journey in academia and industry
    Dr Michael Wilson, Senior Director, Head of Molecular Biology, CSL Limited
  • 3:35pm
    Key learnings, an Academic perspective
    Associate Professor Kaylene Simpson (Head of Victorian Centre for Functional Genomics at the Peter MacCallum Cancer Centre)
  • 3:45pm
    The Role of intellectual property in commercialising scientific research
    Ms Karen Sinclair and Dr Grant Jacobsen, Watermark Intellectual Asset Management
  • 4:15pm
    Open Forum (Q&A) – panel discussion
  • 4:45pm
    Networking & Close

Watch the Sydney Forum 2015 highlights

Watch the Brisbane Forum 2015 highlights

  • 2:00pm
    Welcome and Introduction
    Reich Webber-Montenegro, Director – Marketing, Inside Sales, and Shared Services, Sigma-Aldrich Oceania
  • 2:15pm
    EMCR barriers to commercialisation
    Dr Michael Crichton, University of Queensland
  • 2:25pm
    Tips to successful commercialisation, an Industry perspective
    Ben Perrin, General Manager, SAFC, Sigma-Aldrich Asia Pacific
  • 2:55pm
    Key learnings, an Academic perspective
    Associate Professor Derek Richard, Director of Research, School of Biomedical Sciences, Scientific Director, Cancer & Ageing Research Program, Queensland University of Technology
  • 3:05pm
    Innovation to Solution
    Professor Ian Frazer, Head of Cancer Immunology Program, University of Queensland, Board Chair, TRI Foundation
  • 3:35pm
    Key learnings, an Academic perspective
    Professor Deborah White, Director of Cancer Research, SA Health & Medical Research Institute
  • 3:45pm
    The Role of intellectual property in commercialising scientific research
    Dr Brittany Howard and Dr Grant Jacobsen, Watermark Intellectual Asset Management
  • 4:15pm
    Open Forum (Q&A) – panel discussion
  • 4:45pm
    Networking & Close

Watch the Sydney Forum 2015 highlights

Watch the Melbourne Forum 2015 highlights